Dr. Nemanja Rodic, MD

Dr. Nemanja Rodic, MD

Dr. Nemanja Rodic, MD

Languages: English, Croatian, French, Serbian
Fax: 202-877-8900

Contact this Provider:

  • Dermatopathology
Conditions I Treat
  • basal cell carcinoma
  • cutaneous lymphoma
  • melanoma
  • squamous carcinoma in situ
About the Provider

Nemanja Rodic, MD, PhD, is a board-certified pathologist and Medical Director of Dermatopathology at MedStar Washington Hospital Center. He’s a member of the College of American Pathologists and the American Society for Dermatopathology, where he also serves as a membership committee member.

As a specialist in Dermatopathology, Dr. Rodic interprets skin and nail biopsies (both pediatric and adult) collected for signs of skin cancer. He is highly experienced with complex cases and actively participates in weekly meetings of multidisciplinary specialties to discuss patient treatments, ensuring that diagnoses are clear.

His clinical interests include distinguishing melanocytic nevi from melanomas. His research interests include using a dermoscope to examine skin biopsies for additional diagnostic features after they’ve been procured, and before they are prepared onto a slide for analysis under the microscope. Dermoscopy has the potential to improve the diagnostic accuracy. In Dr. Rodic’s laboratory, immunohistochemistry is used to confirm and secure cancer diagnoses. His team constantly updates their immunohistochemistry diagnostic panel based on current research findings.

Dr. Rodic completed his PhD in molecular biology from the University of Florida, Gainesville, before receiving his medical degree from George Washington School of Medicine. Following this, he joined Johns Hopkins University for an internship and a four-year residency in pathology. Dr. Rodic continued his training at Yale University, where he completed a two-year fellowship in Dermatopathology, followed by a specialty fellowship in Molecular Genetic Pathology.

In addition to receiving numerous awards throughout his education and training, Dr. Rodic also holds three patents, including a diagnostic biomarker for skin cancer developed from a mouse monoclonal antibody.

Dr. Rodic is fluent in Serbian and has achieved an intermediate level of written and spoken French. When not analyzing complex skin biopsies, Dr. Rodic enjoys reading philosophy, more specifically stoicism.

Philosophy of Care

"Pathology is a crucial part of developing any treatment plan. My priority is to carefully analyze each biopsy in a methodical and detail-oriented way in order to confidently deliver an accurate diagnosis."

"I approach each case the same way a clinician behaves when he/she is with a patient in the exam room. Even though my work is performed in a laboratory, I always act as if the patient is right there with me while examining biopsies."

"I work with a talented team of board-certified dermatopathologists that meet daily to discuss higher complexity cases. We are thrilled to be a part of patient care."

  • Fellowship Program: Yale New Haven Hospital (2017)
  • Fellowship Program: Yale New Haven Hospital (2016)
  • Residency Program: Johns Hopkins Hospital (2014)
  • Medical School: George Washington University School of Medicine (2009)
  • Board Certification: American Board of Pathology, Anatomic Pathology
  • Board Certification: American Board of Pathology, Clinical Pathology
  • Board Certification: American Board of Pathology, Dermatopathology

1. Oka M, Meacham AM, Hamazaki T, Rodić N, Chang L-J, Terada N, De novo DNA
Methyltransferases Dnmt3a and Dnmt3b Primarily Mediate the Cytotoxic Effect of 5-aza-2'
deoxycytidine, Oncogene 2005 Apr; 24(19):3091-9.
2. Rodić N, Oka M, Hamazaki T, Murawski MR, Jorgensen M, Maatouk DM, Resnick JL, Li E,
Terada N, DNA Methylation is Required for Silencing of Ant4, An Adenine Nucleotide
Translocase, Selectively Expressed in Mouse Embryonic Stem Cells and Germ Cells, Stem
Cells 2005 Oct;23(9):1314-23.
3. Oka M, Rodić N, Graddy J, Chang L-J, Terada, N, Cpg Sites Preferentially Methylated By Dnmt
3a, J. Biol. Chem. 2010 Jul;38(13):4313-24.
4. Rodić N, Brower JV, Seki T, Jorgensen M, Fliess N, Yachnis AT, McCarrey JR, Oh, SP, Terada,
N, Evolutionarily Conserved Mammalian Adenine Nucleotide Translocase 4 Is Essential For
Spermatogenesis, J. Biol. Chem. 2007 Oct 5;282(40):29658-66.
5. Rodić N, Maleki Z, Cytomorphologic findings of Schneiderian papilloma: A Case Report. Diagn.
Cytopathol. 2012 Dec;40(12):1100-3.
6. Rodić N, Burns KH, TCF3-PBX1 translocations from ALLs involve interspersed repeat elements,
Mobile DNA 2013 Oct 17;4(1):22.
7. Rodić N, Taube JM, Manson P, Patel M. Patterson JW, and Erdag G, Locally Invasive Dermal
Squamomelanocytic Tumor with Matrical Differentiation: A Peculiar Case With Review of the
Literature., Am. J. Dermatopathol. 2013 Jun;35(4):e72-6.
8. Rodić N, Sharma R, Zampella J, Iacobuzio-Donahue CA, Maitra A, Shih I, Montgomery EA,
Gabrielson E, Netto GJ, Westra W, Eberhart CG, and Burns KH, Long INterspersed Element-1
(LINE-1) protein expression is a hallmark of many human cancers, Am. J. of Path. 2014 May;
9. Rodić N, Anders RA, Eshleman JR, Lin MT, Xu H, Kim JH, Beierl K, Chen S, Luber BS,Wang H,
Topalian SL, Pardoll DM, Taube JM. PD-L1 expression in melanocytic lesions does not
correlate with the BRAF V600E mutation. Cancer. Immunol. Res. 2015 Feb;3(2):110-5.
10. Rodić N, Zampella J, Sharma R, Burns KH, and Taube JM, Diagnostic utility of 5-
hydroxymethylcytosine immunohistochemistry in melanocytic proliferations., J. of Cutan. Pathol.
2015 Aug 4.
11. Doucet-O'Hare TT, Rodić N, Sharma R, Darbari I, Abril G, Choi JA, Young Ahn J, Cheng Y,
Anders RA, Burns KH, Meltzer SJ, Kazazian HH Jr. LINE-1 expression and retrotransposition in
Barrett’s esophagus and esophageal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2015 Sep
12. Rodić N, Sharma R, Makohon-Moore A, Mita P, Dai D, A. Iacobuzio-Donahue CA, Boeke JD,
and Burns KH, Somatic Retrotransposition Drives Clonal Genetic Variation in Pancreatic Ductal
Adenocarcinoma, Nature Medicine 2015 Sep;21(9):160-4.
13. Theodosakis N, Micevic G, Sharma R, Baras AS, Lazova R, Bosenberg MW, and Rodić N
Integrative discovery of CD98 as a Melanoma Biomarker, Pigment. Cell. Melanoma. Res., 2016
2016 May;29(3):385-7.
14. Sharma R, Rodić N, Burns KH, Taylor MS, Immunodetection of Human LINE-1 Expression in
Cultured Cells and Human Tissues, Methods Mol. Biol. 2016 1400;261-80.
15. Theodosakis N, Micevic G, Bosenberg MW, and Rodić N Cell & Tissue Display (CTD): an
alternative multipurpose tool for microscopy, J. Histochem. Cytochem. 2016 2016 Jul;64(7):403-
16. Criscione SW, Theodosakis N, Micevic G, Cornish TC, Burns KH, Neretti N, and Rodić N
Transcription of LINE-1 antisense promoters drive diverse fusion transcripts in both human
health and disease, BMC Genomics. 2016 Jun 14;17(1):463.
17. Rodić N, Srisuttiyakorn C, Bulloch K, Bosenberg M, Ariyan S, Narayan D, Gould Rothberg BE,
Galan A, Intratumoral multinucleated giant cells are not a prognosticating pathologic feature in
cutaneous malenanoma, J. of Cutan. Pathol. 2016 2016 Oct;43(10):821-9.
18. Shi VJ, Rodić N, Gettinger S, Leventhal JS, Neckman JP, Girardi M, Bosenberg M, Choi JN,
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-
Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy, JAMA
Dermatol. 2016 Jul 13.
19. Zampella JG, Rodić N, Yang WR, Huang CR, Welch J, Gnanakkan VP, Cornish TC, Boeke JD,
Burns KH, A map of mobile DNA insertions in the NCI-60 human cancer cell panel, Mob DNA.
2016 Oct 31;7:20.
20. Achanta P, Steranka JP, Tang Z, Rodić N, Sharma R, Yang WR, Ma S, Grivainis M, Huang CR,
Schneider AM, Gallia GL, Riggins GJ, Quinones-Hinojosa A, Fenyö D, Boeke JD, Burns KH,
Somatic retrotransposition is infrequent in glioblastomas, Mob DNA. 2016 Nov 11;7:22.
21. Micevic G, Theodosakis N, Taube JM, Bosenberg MW, Rodić N, Attenuation of Genomewide 5-
methylcytosine Level Is an Epigenetic Feature of Cutaneous Malignant Melanomas, Melanoma
Res. 2016 Dec 16.
22. Tang Z, Steranka JP, Ma S, Grivainis M, Rodić N, Huang CL , Shih I, Wang T, Boeke JD, Fenyö
D, Burns KH, Human Transposon Insertion Profiling: Analysis, visualization and identification of
somatic LINE-1 insertions in ovarian cancer Proc Natl Acad Sci U S A. 2017 Jan 16.
23. Rodić N, Glusac EJ, Comment on Detection of Occult Invasion in Melanoma in Situ, JAMA
Dermatol. 2017 Apr 5.
24. Ko CJ, Glusac EJ, McNiff JM, Rodić N, Leffell DJ, Squamous proliferations of the legs of
women: Quantitative examination of histopathology, TP53 sequencing, and implications for
diagnosis in a series of 30 cases, J Am Acad Dermatol. 2017 Jul 11.
25. Cocks M, Rehman J, Barker N, Auerbach J, Cowper S, , Rodić N: How to take better
photomicrographs: a step-wise approach, J. of Cutan. Pathol. 2018 Feb 27.


1. Rodić N, Rutenberg MS, Terada N, Cell Fusion and Reprogramming: Resolving our
Transdifferences, Trends Mol. Med. 2004 10:93-96.
2. Rodić N, Burns KH, Long interspersed element-1 (L1) expression in human neoplasms, PLoS
Genetics 2013 Mar;9(3).
3. Rodić N (2016), Long interspersed element-1 (L1) Retrotransposons as Neoplastic Biomarkers,
Gael Cristofari (Ed.) Human Retrotransposons in Health and Disease, Springer Science, Paris,
2016 (Aug), ISBN: 978-3-319-48343-6.
4. Rodić N (2018), Long interspersed element-1 (LINE-1) Regulation and Activity in Cancer, Front
Biosci (Landmark Ed). 2018 Mar 1;23:1680-1686. Front Biosci (Landmark Ed). 2018 Mar

Practice Locations
Member of Medical Staff
  • MedStar Washington Hospital Center
  • MedStar Georgetown University Hospital
  • 2000 Grinter Scholarship, University of Florida, College of Medicine
  • 2001 Certificate of Achievement for Outstanding Academic
  • Accomplishment, University of Florida, College of Medicine
  • 2003 Medical Guild Research Incentive Award, University of Florida, College of Medicine
  • 2003 Alec Courtelis Award, University of Florida, College of Medicine
  • 2005 Keystone Symposia Scholarship, University of Florida, College of Medicine
  • 2009 Gold Humanism in Medicine Award, George Washington University, School of Medicine
  • 2011 Travel Award, Pathology Informatics Conference
  • 2012 The Sol Goldman Pancreatic Cancer Research Center Grant, funds awarded (first award) $ 50,000
  • 2013 The Fred and Janet Sanfilippo Research Fund Award, funds awarded $ 5,000
  • 2013 The HERA foundation Award, funds awarded $ 20,000
  • 2014 The Sol Goldman Pancreatic Cancer Research Center Grant, funds awarded (second award) $ 50,000
  • 2015 Dermatopathology Trainee World Cup, First Place Winner, International Society of Dermatopathology, San Francisco, CA
  • 2017 Clinical Research Committee Award, University of Florida, Gainesville, FL awarded $6,708